Stay updated on PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.

Latest updates to the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe webpage has been updated to include new dosing information for the drug PF-06480605 in the treatment of moderate to severe ulcerative colitis, along with a revision update to version 2.15.0. The previous detailed study description and inclusion/exclusion criteria have been removed.SummaryDifference10%
- Check17 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check24 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check60 days agoChange DetectedThe webpage has removed important notices regarding service performance and contact information for assistance, which may impact user experience.SummaryDifference1%
- Check74 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check82 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
Stay in the know with updates to PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.